Last updated on October 2018

A Pilot Study of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders


Brief description of study

The main objective of this exploratory 8-week pilot study is to evaluate the safety and efficacy of buspirone for the treatment of anxiety in youth (ages 6-17 years) with autism spectrum disorders. The study results will be used to generate hypotheses for a larger randomized-controlled trial with explicit hypotheses and sufficient statistical power.

Clinical Study Identifier: NCT03432065

Contact Investigators or Research Sites near you

Start Over

Nina Dallenbach, BS

Massachusetts General Hospital
Boston, MA United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.